(Q43604625)

25 November 2017

Enhancing the potency of peptide-pulsed antigen presenting cells by vector-driven hyperexpression of a triad of costimulatory molecules (English)

1 reference

25 November 2017

Hodge JW

1

1 reference

25 November 2017

Grosenbach DW

2

1 reference

25 November 2017

Rad AN

3

1 reference

25 November 2017

Giuliano M

4

1 reference

25 November 2017

Sabzevari H

5

1 reference

25 November 2017

Schlom J

6

1 reference

25 November 2017

language of work or name

English

0 references

publication date

1 May 2001

1 reference

25 November 2017

1 reference

25 November 2017

19

1 reference

25 November 2017

3552-3567

1 reference

25 November 2017

25-26

1 reference

Costimulation of T-cell-mediated tumor immunity.

25 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900062-7

7 January 2021

Co-expression of B7-1 and ICAM-1 on tumors is required for rejection and the establishment of a memory response.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900062-7

7 January 2021

Immunotherapy of cancer with dendritic-cell-based vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900062-7

7 January 2021

Generation of dendritic cells from bone marrow progenitors using GM-CSF, TNF-alpha, and additional cytokines: antagonistic effects of IL-4 and IFN-gamma and selective involvement of TNF-alpha receptor-1

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900062-7

7 January 2021

Fetal calf serum-free generation of functionally active murine dendritic cells suitable for in vivo therapeutic approaches

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900062-7

7 January 2021

Enhanced activation of T cells by dendritic cells engineered to hyperexpress a triad of costimulatory molecules

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900062-7

7 January 2021

Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900062-7

7 January 2021

Formation of Lentivirus Particles by Mammalian Cells Infected with Recombinant Fowlpox Virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900062-7

7 January 2021

Compact, synthetic, vaccinia virus early/late promoter for protein expression.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900062-7

7 January 2021

Sequence and transcriptional analysis of the vaccinia virus HindIII I fragment

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900062-7

7 January 2021

Distinctive nucleotide sequences adjacent to multiple initiation and termination sites of an early vaccinia virus gene

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900062-7

7 January 2021

Peptide-specific activation of cytolytic CD4+ T lymphocytes against tumor cells bearing mutated epitopes of K-ras p21.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900062-7

7 January 2021

Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900062-7

7 January 2021

Exact prediction of a natural T cell epitope

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900062-7

7 January 2021

RMA/S cells present endogenously synthesized cytosolic proteins to class I-restricted cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900062-7

7 January 2021

Bone marrow-generated dendritic cells pulsed with a class I-restricted peptide are potent inducers of cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900062-7

7 January 2021

Comparative analysis of murine dendritic cells derived from spleen and bone marrow

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900062-7

7 January 2021

Improved efficacy of dendritic cell vaccines and successful immunization with tumor antigen peptide-pulsed peripheral blood mononuclear cells by coadministration of recombinant murine interleukin-12

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900062-7

7 January 2021

Proliferating dendritic cell progenitors in human blood

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900062-7

7 January 2021

Induction of CD8+ cytotoxic T lymphocytes by immunization with syngeneic irradiated HIV-1 envelope derived peptide-pulsed dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900062-7

7 January 2021

Expression of B7 costimulator molecules on mouse dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900062-7

7 January 2021

Bone marrow-derived dendritic cell progenitors (NLDC 145+, MHC class II+, B7-1dim, B7-2-) induce alloantigen-specific hyporesponsiveness in murine T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900062-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900062-7

1 reference

7 January 2021

CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-XL.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900062-7

7 January 2021

Increased survival of patients treated with a vaccinia melanoma oncolysate vaccine: second interim analysis of data from a phase III, multi-institutional trial

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900062-7

7 January 2021

Favorable clinical responses in subsets of patients from a randomized, multi-institutional melanoma vaccine trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900062-7

7 January 2021

Does B7-1 expression confer antigen-presenting cell capacity to tumors in vivo?

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900062-7

7 January 2021

Induction of human cytotoxic T lymphocytes by artificial antigen-presenting cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900062-7

7 January 2021

Phase I/IIa safety, immunogenicity, and efficacy trial of NYVAC-Pf7, a pox-vectored, multiantigen, multistage vaccine candidate for Plasmodium falciparum malaria.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900062-7

7 January 2021

Diversified prime and boost protocols using recombinant vaccinia virus and recombinant non-replicating avian pox virus to enhance T-cell immunity and antitumor responses

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900062-7

7 January 2021

10.1016/S0264-410X(01)00062-7

Identifiers

DOI

1 reference

25 November 2017

1 reference